Navigation Links
Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
Date:10/11/2011

MOUNTAIN VIEW, Calif., Oct. 11, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the company will present at the 18th Annual NewsMakers in the Biotech Industry conference, taking place Friday, October 21, 2011 in New York City.  The Alexza corporate presentation will be at 9:30 a.m. ET.  The presentation will be webcast live.

To access the presentation via the Web, please go to the Investor Relations tab at www.alexza.com or directly www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ALXA&item_id=4209599.  A replay of the webcast will be available approximately 24 hours after the presentation and archived for 14 days.

About Alexza Pharmaceuticals, Inc.

Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

Adasuve™ (Staccato loxapine), Alexza's lead program, is being developed for the rapid treatment of agitation in adults with schizophrenia or bipolar disorder.  Alexza completed and announced positive results from both of its Phase 3 clinical trials a
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Mail-service and specialty ... consumers, employers and government health plans $11.8 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
(Date:3/4/2015)... UPM Pharmaceuticals, a division of Gregory Pharmaceutical ... to manufacture Flibanserin 100 mg tablets. Sprout has submitted ... drug approved to treat hypoactive sexual desire disorder (HSDD), ... The tablets will be manufactured at UPM,s 475,000 ... . Dr. John M. Gregory , ...
(Date:3/4/2015)... 2015   Aratana Therapeutics, Inc . (NASDAQ: ... the licensing, development and commercialization of innovative biopharmaceutical products ... at the Barclays Global Healthcare Conference to ... Beach Hotel in Miami , FL.  ... President and Chief Executive Officer of Aratana Therapeutics, will ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2
... 25, 2007 /PRNewswire-FirstCall/ --,Phosphagenics Limited (AIM: PSG) announced ... dermal drug delivery,technology formulated with retinoic acid, a ... ingredient used in,anti-aging cosmetics. , The proof of ... of retinoic acid delivered into the skin when ...
... Pfizer announced today,that Lipitor (atorvastatin calcium) Tablets 80 ... events and major coronary events,in type 2 diabetes ... who had experienced a recent stroke or mini-stroke, ... analysis of the landmark,Stroke Prevention by Aggressive Reduction ...
Cached Medicine Technology:Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 3
(Date:3/4/2015)... March 04, 2015 With the growing influence ... lives of our teens and young adults, combined with the ... and confusing to try to keep up with what kids ... or trend is replaced on a daily basis. , The ... and the slang that is used to discreetly talk about ...
(Date:3/4/2015)... BC (PRWEB) March 04, 2015 Starting ... perform LASIK and PRK procedures at their new location ... Correction, Dr. Joseph King and Dr. Gabriel Chu also ... practice in Surrey is named Fraser Valley Cataract and ... is accredited by the College of Physicians and Surgeons ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... within the centerfold of The San Francisco Chronicle with ... readership of 500,000 readers. Its digital component is distributed ... a network of top news sites and partner outlets. ... click here. , Milorganite is composed of ...
(Date:3/4/2015)... 04, 2015 As seen on ... can be a painful condition in which the ... of the uterus leading to very unpleasant symptoms and ... can have a terrible effect on women’s quality of ... the most common cause of infertility in women and ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The popular ... of their new L-Style Revolution™ Program. The customized program ... and women of all health and fitness levels to ... goals faster than traditional methods. , “We’re really proud ... customized plans based on award winning techniques to help ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2
... gum disease , , WEDNESDAY, Dec. 12 (HealthDay News) ... and a weakened immune response may be to blame, ... In experiments with mice infected with the bacteria ... battle gum infection than their normal-weight counterparts, according to ...
... 12 CG Technology has changed its,name to ... depth,and breadth of services it offers. Carlisle & ... standards of work, while focusing its,business on the ... Consulting Group (CG) is a management consulting,and project-based ...
... System Detects Illegal Payments and Providers, AUSTIN, ... and an NBC News report, U.S. taxpayers are ... to unqualified doctors and health,care providers. A new ... however, can make a significant impact on reducing ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ... today announced that James L. Cox, M.D. has,agreed ... Cox, reputation as a,preeminent authority in the surgical ... serves as the foundation for ATS 3f(R),tissue valve ...
... We are encouraged by the,positive results of the ... D.C., showing promising strides in the right direction,with significant ... of a larger trend for all measured age groups ... past six years (2001-2007)., MTF, now in its ...
... presents $5,000 each to six community organizations in ... underserved areas, ... it will provide a total of $30,000 in end of,year donations to ... given to six agencies in northern and,southern California to assist vulnerable populations., ...
Cached Medicine News:Health News:Obesity Weakens Immune Response 2Health News:Technology can Dramatically Reduce Billions of Dollars in Medicaid, Medicare Fraud 2Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 2Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 2Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study 4Health News:Blue Cross of California Gives $30,000 in Holiday Donations to Food Banks Throughout the State 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: